The association of statin therapy with the risk of recurrent venous thrombosis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jth.13334PMID 27061794PMCID PMC4966556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.

  2015cited by this paper
• Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration

  2014cited by this paper
• Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case–control study

  2014cited by this paper
• Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

  2014cited by this paper
• Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.

  2014cited by this paper
• Statin treatment and the risk of recurrent pulmonary embolism.

  2013cited by this paper
• Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study

  2013cited by this paper
• Statin treatment and the risk of recurrent pulmonary embolism.

  2013cited by this paper
• Lipid lowering drugs and the risk of recurrent venous thromboembolism.

  2012cited by this paper
• Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials

  2012cited by this paper
• Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis Processes

  2012cited by this paper
• Statins, inflammation and deep vein thrombosis: a systematic review

  2012cited by this paper
• Statins and Venous Thrombosis: A Story Too Good to Be True?

  2012cited by this paper
• Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

  2011cited by this paper
• Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5

  2009cited by this paper
• A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

  2009cited by this paper
• Mechanisms of venous thrombosis and resolution.

  2008cited by this paper
• Multiple imputation of discrete and continuous data by fully conditional specification

  2007cited by this paper
• Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes.

  2007cited by this paper
• Association of genetic variations with nonfatal venous thrombosis in postmenopausal women.

  2007cited by this paper
• Endothelial dysfunction in patients with spontaneous venous thromboembolism.

  2007cited by this paper
• Effect of Fluvastatin and Valsartan, Alone and in Combination, on Postprandial Vascular Inflammation and Fibrinolytic Activity in Patients With Essential Hypertension

  2007cited by this paper
• Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease

  2006cited by this paper
• Simvastatin treatment improves endothelial function and increases fibrinolysis in patients with hypercholestrolemia.

  2006cited by this paper
• Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia

  2005cited by this paper
• Statins and Blood Coagulation

  2004cited by this paper
• Evaluating medication effects outside of clinical trials: new-user designs.

  2003cited by this paper
• Atorvastatin reduces plasma levels of factor VII activity and factor VII antigen in patients with hyperlipidemia.

  2002cited by this paper
• Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation

  2001cited by this paper
• Partially parametric techniques for multiple imputation

  1996cited by this paper
• Proportional hazards tests and diagnostics based on weighted residuals

  1994cited by this paper

• Association of lipid-lowering drugs with venous thromboembolism outcomes: a phenome-wide association study and a drug-target Mendelian randomization study.

  2025cites this paper
• Clinical Outcomes Associated with Statin Use in Pulmonary Embolism: A Systematic Review of Observational Studies

  2025influential citation
• Physical activity before venous thromboembolism and risk of recurrence in a population-based inception cohort

  2025influential citation
• Effect of Rosuvastatin on Murine Model of Deep Vein Thrombosis

  2025cites this paper
• Thrombotic antiphospholipid syndrome: From guidelines to clinical management.

  2024cites this paper
• External validation of the Leiden Thrombosis Recurrence Risk Prediction models (L-TRRiP) for the prediction of recurrence after a first venous thrombosis in the Heart and Vascular Health study

  2024cites this paper
• Statins and risk of venous thromboembolic diseases: A two-sample mendelian randomization study.

  2023cites this paper
• Postoperative statin therapy is not associated with reduced incidence of venous thromboembolic events following kidney transplantation

  2022cites this paper
• Incident thrombus location and predicting risk of recurrent venous thromboembolism

  2022cites this paper
• Statin therapy in venous thromboembolism: How far from primary and secondary prevention?

  2022cites this paper
• Prevention and Management of Deep Vein Thrombosis and Pulmonary Embolism

  2022cites this paper
• Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial

  2021cites this paper
• Tiefe Beinvenenthrombosen bei Intensivpatienten mit COVID-19-Infektion – Einfluss eines standardisierten Therapieregimes

  2021cites this paper
• Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study

  2021cites this paper
• Effect of statins on the risk of recurrent venous thromboembolism: A systematic review and meta-analysis.

  2021cites this paper
• BinomiRare: A robust test for association of a rare genetic variant with a binary outcome for mixed models and any case-control proportion

  2021cites this paper
• Statin Therapy and the Incidence of Thromboembolism and Vascular Events Following Liver Transplantation

  2021cites this paper
• Arterial and venous thrombosis: What's the link? A narrative review.

  2020cites this paper
• Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis.

  2020cites this paper
• Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.

  2019cites this paper
• Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review

  2019cites this paper
• Rosuvastatin use improves measures of coagulation in patients with venous thrombosis

  2018cites this paper
• Stabilization of symptomatic carotid atherosclerotic plaques by statins: a clinico-pathological analysis

  2018cites this paper
• Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study

  2017cites this paper
• Statins as a preventative therapy for venous thromboembolism.

  2017cites this paper
• Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs.

  2017cites this paper
• Pharmacological management of pulmonary embolism

  2017cites this paper
• Perioperative Venous Thromboembolism: A Review

  2017cites this paper
• Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies

  2017cites this paper
• Natural terpenoid glycosides with in vitro/vivo antithrombotic profiles from the leaves of Crataegus pinnatifida

  2017cites this paper
• Optimization of monitoring and management of anticoagulant therapy

  2017cites this paper
• Identification of Genetic Variants Linking Protein C and Lipoprotein Metabolism: The ARIC Study (Atherosclerosis Risk in Communities)

  2017cites this paper
• A thrombotic storm

  2017cites this paper
• Medical Management of Pulmonary Embolism: Beyond Anticoagulation.

  2017cites this paper
• Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.

  2016cites this paper
• VTE AND SURGERY — THE SCOPE OF THE PROBLEM

  year unknowncites this paper